Skip to main content

Child, Only

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Forte Biosciences
1 program
Child Centred Health DialogN/A1 trial
Active Trials
NCT04260672Completed6,047Est. Dec 2021
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Pediatric Medication Therapy ManagementN/A1 trial
Active Trials
NCT05761847Recruiting371Est. Jan 2028

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Colorado TherapeuticsPediatric Medication Therapy Management
Forte BiosciencesChild Centred Health Dialog

Clinical Trials (2)

Total enrollment: 6,418 patients across 2 trials

NCT05761847Colorado TherapeuticsPediatric Medication Therapy Management

Pediatric Medication Therapy Management Trial

Start: Sep 2023Est. completion: Jan 2028371 patients
N/ARecruiting
NCT04260672Forte BiosciencesChild Centred Health Dialog

Child-Centred Health Dialogue in Child Health Services

Start: Jan 2017Est. completion: Dec 20216,047 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 6,418 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.